Aardvark Therapeutics, Inc.Aardvark Therapeutics, Inc.Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪211.92 M‬USD
‪−7.21 M‬USD
0.00USD
‪12.21 M‬
Beta (1Y)
3.63

About Aardvark Therapeutics, Inc.


CEO
Tien Li Lee
Headquarters
San Diego
Founded
2017
FIGI
BBG01223DLB2
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as AARD.

Frequently Asked Questions


The current price of AARD is 9.09 USD — it has decreased by −6.76% in the past 24 hours. Watch Aardvark Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aardvark Therapeutics, Inc. stocks are traded under the ticker AARD.
AARD stock has fallen by −5.71% compared to the previous week, the month change is a −48.00% fall, over the last year Aardvark Therapeutics, Inc. has showed a −40.12% decrease.
We've gathered analysts' opinions on Aardvark Therapeutics, Inc. future price: according to them, AARD price has a max estimate of 50.00 USD and a min estimate of 21.00 USD. Watch AARD chart and read a more detailed Aardvark Therapeutics, Inc. stock forecast: see what analysts think of Aardvark Therapeutics, Inc. and suggest that you do with its stocks.
AARD reached its all-time high on Feb 20, 2025 with the price of 19.58 USD, and its all-time low was 8.60 USD and was reached on Mar 20, 2025. View more price dynamics on AARD chart.
See other stocks reaching their highest and lowest prices.
AARD stock is 8.92% volatile and has beta coefficient of 3.63. Track Aardvark Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Aardvark Therapeutics, Inc. there?
Yes, you can track Aardvark Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Aardvark Therapeutics, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
AARD net income for the last quarter is ‪−4.18 M‬ USD, while the quarter before that showed ‪−2.04 M‬ USD of net income which accounts for −104.90% change. Track more Aardvark Therapeutics, Inc. financial stats to get the full picture.
No, AARD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AARD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aardvark Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.